The “BRIC Cardiac Rhythm Management Devices Outlook to 2036” is a comprehensive databook report, covering key market data on the BRIC Cardiac Rhythm Management Devices market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Cardiac Resynchronisation Therapy (CRT), Implantable Cardioverter Defibrillators (ICD) and Pacemakers
The BRIC Cardiac Rhythm Management Devices Market report provides key information and data on:
- Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2024 to 2036.
- 2025 company share data for Cardiac Rhythm Management Devices Market.
- Global corporate-level profiles of key companies operating within the BRIC Cardiac Rhythm Management Devices Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.
Scope
BRIC Cardiac Rhythm Management Devices is segmented as follows:
- Cardiac Resynchronisation Therapy (CRT)
- Implantable Cardioverter Defibrillators (ICD)
- Pacemakers
Reasons to Buy
The BRIC Cardiac Rhythm Management Devices Market report helps you to develop:
- Business strategies by identifying the key market segments poised for strong growth in the future.
- Market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- Understand the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.
Table of Contents
1 Introduction
1.1 What Is This Report About?
1.2 Cardiac Rhythm Management Devices Market Segmentation
1.3 Definitions of Markets Covered in the Report
1.2 Cardiac Rhythm Management Devices Market Segmentation
1.3 Definitions of Markets Covered in the Report
2 Cardiac Rhythm Management Devices Market, EU5
2.1 Cardiac Rhythm Management Devices Market, EU5, Revenue ($m), 2024-2036
2.2 Cardiac Rhythm Management Devices Market, EU5, Revenue ($m), 2024-2036
2.3 Cardiac Rhythm Management Devices Market, EU5, Volume (Units), 2024-2036
2.4 Cardiac Rhythm Management Devices Market, EU5, Volume (Units), 2024-2036
2.5 Cardiac Rhythm Management Devices Market, EU5, Company Share by Revenue ($m), 2025
2.2 Cardiac Rhythm Management Devices Market, EU5, Revenue ($m), 2024-2036
2.3 Cardiac Rhythm Management Devices Market, EU5, Volume (Units), 2024-2036
2.4 Cardiac Rhythm Management Devices Market, EU5, Volume (Units), 2024-2036
2.5 Cardiac Rhythm Management Devices Market, EU5, Company Share by Revenue ($m), 2025
3 Cardiac Rhythm Management Devices Market, France
3.1 Cardiac Rhythm Management Devices Market, France, Revenue ($m), 2024-2036
3.1.1 Cardiac Resynchronisation Therapy (CRT) Market, France, Revenue ($m), by Segment, 2024-2036
3.1.2 Implantable Cardioverter Defibrillators (ICD) Market, France, Revenue ($m), by Segment, 2024-2036
3.1.3 Pacemakers Market, France, Revenue ($m), by Segment, 2024-2036
3.2 Cardiac Rhythm Management Devices Market, France, Volume (Units), 2024-2036
3.2.1 Cardiac Resynchronisation Therapy (CRT) Market, France, Volume (Units), by Segment, 2024-2036
3.2.2 Implantable Cardioverter Defibrillators (ICD) Market, France, Volume (Units), by Segment, 2024-2036
3.2.3 Pacemakers Market, France, Volume (Units), by Segment, 2024-2036
3.3 Cardiac Rhythm Management Devices Market, France, Average Price ($), 2024-2036
3.4 Cardiac Rhythm Management Devices Market, France, Company Share by Revenue ($m), 2025
3.1.1 Cardiac Resynchronisation Therapy (CRT) Market, France, Revenue ($m), by Segment, 2024-2036
3.1.2 Implantable Cardioverter Defibrillators (ICD) Market, France, Revenue ($m), by Segment, 2024-2036
3.1.3 Pacemakers Market, France, Revenue ($m), by Segment, 2024-2036
3.2 Cardiac Rhythm Management Devices Market, France, Volume (Units), 2024-2036
3.2.1 Cardiac Resynchronisation Therapy (CRT) Market, France, Volume (Units), by Segment, 2024-2036
3.2.2 Implantable Cardioverter Defibrillators (ICD) Market, France, Volume (Units), by Segment, 2024-2036
3.2.3 Pacemakers Market, France, Volume (Units), by Segment, 2024-2036
3.3 Cardiac Rhythm Management Devices Market, France, Average Price ($), 2024-2036
3.4 Cardiac Rhythm Management Devices Market, France, Company Share by Revenue ($m), 2025
4 Cardiac Rhythm Management Devices Market, Germany
4.1 Cardiac Rhythm Management Devices Market, Germany, Revenue ($m), 2024-2036
4.1.1 Cardiac Resynchronisation Therapy (CRT) Market, Germany, Revenue ($m), by Segment, 2024-2036
4.1.2 Implantable Cardioverter Defibrillators (ICD) Market, Germany, Revenue ($m), by Segment, 2024-2036
4.1.3 Pacemakers Market, Germany, Revenue ($m), by Segment, 2024-2036
4.2 Cardiac Rhythm Management Devices Market, Germany, Volume (Units), 2024-2036
4.2.1 Cardiac Resynchronisation Therapy (CRT) Market, Germany, Volume (Units), by Segment, 2024-2036
4.2.2 Implantable Cardioverter Defibrillators (ICD) Market, Germany, Volume (Units), by Segment, 2024-2036
4.2.3 Pacemakers Market, Germany, Volume (Units), by Segment, 2024-2036
4.3 Cardiac Rhythm Management Devices Market, Germany, Average Price ($), 2024-2036
4.4 Cardiac Rhythm Management Devices Market, Germany, Company Share by Revenue ($m), 2025
4.1.1 Cardiac Resynchronisation Therapy (CRT) Market, Germany, Revenue ($m), by Segment, 2024-2036
4.1.2 Implantable Cardioverter Defibrillators (ICD) Market, Germany, Revenue ($m), by Segment, 2024-2036
4.1.3 Pacemakers Market, Germany, Revenue ($m), by Segment, 2024-2036
4.2 Cardiac Rhythm Management Devices Market, Germany, Volume (Units), 2024-2036
4.2.1 Cardiac Resynchronisation Therapy (CRT) Market, Germany, Volume (Units), by Segment, 2024-2036
4.2.2 Implantable Cardioverter Defibrillators (ICD) Market, Germany, Volume (Units), by Segment, 2024-2036
4.2.3 Pacemakers Market, Germany, Volume (Units), by Segment, 2024-2036
4.3 Cardiac Rhythm Management Devices Market, Germany, Average Price ($), 2024-2036
4.4 Cardiac Rhythm Management Devices Market, Germany, Company Share by Revenue ($m), 2025
5 Cardiac Rhythm Management Devices Market, Italy
5.1 Cardiac Rhythm Management Devices Market, Italy, Revenue ($m), 2024-2036
5.1.1 Cardiac Resynchronisation Therapy (CRT) Market, Italy, Revenue ($m), by Segment, 2024-2036
5.1.2 Implantable Cardioverter Defibrillators (ICD) Market, Italy, Revenue ($m), by Segment, 2024-2036
5.1.3 Pacemakers Market, Italy, Revenue ($m), by Segment, 2024-2036
5.2 Cardiac Rhythm Management Devices Market, Italy, Volume (Units), 2024-2036
5.2.1 Cardiac Resynchronisation Therapy (CRT) Market, Italy, Volume (Units), by Segment, 2024-2036
5.2.2 Implantable Cardioverter Defibrillators (ICD) Market, Italy, Volume (Units), by Segment, 2024-2036
5.2.3 Pacemakers Market, Italy, Volume (Units), by Segment, 2024-2036
5.3 Cardiac Rhythm Management Devices Market, Italy, Average Price ($), 2024-2036
5.4 Cardiac Rhythm Management Devices Market, Italy, Company Share by Revenue ($m), 2025
5.1.1 Cardiac Resynchronisation Therapy (CRT) Market, Italy, Revenue ($m), by Segment, 2024-2036
5.1.2 Implantable Cardioverter Defibrillators (ICD) Market, Italy, Revenue ($m), by Segment, 2024-2036
5.1.3 Pacemakers Market, Italy, Revenue ($m), by Segment, 2024-2036
5.2 Cardiac Rhythm Management Devices Market, Italy, Volume (Units), 2024-2036
5.2.1 Cardiac Resynchronisation Therapy (CRT) Market, Italy, Volume (Units), by Segment, 2024-2036
5.2.2 Implantable Cardioverter Defibrillators (ICD) Market, Italy, Volume (Units), by Segment, 2024-2036
5.2.3 Pacemakers Market, Italy, Volume (Units), by Segment, 2024-2036
5.3 Cardiac Rhythm Management Devices Market, Italy, Average Price ($), 2024-2036
5.4 Cardiac Rhythm Management Devices Market, Italy, Company Share by Revenue ($m), 2025
6 Cardiac Rhythm Management Devices Market, Spain
6.1 Cardiac Rhythm Management Devices Market, Spain, Revenue ($m), 2024-2036
6.1.1 Cardiac Resynchronisation Therapy (CRT) Market, Spain, Revenue ($m), by Segment, 2024-2036
6.1.2 Implantable Cardioverter Defibrillators (ICD) Market, Spain, Revenue ($m), by Segment, 2024-2036
6.1.3 Pacemakers Market, Spain, Revenue ($m), by Segment, 2024-2036
6.2 Cardiac Rhythm Management Devices Market, Spain, Volume (Units), 2024-2036
6.2.1 Cardiac Resynchronisation Therapy (CRT) Market, Spain, Volume (Units), by Segment, 2024-2036
6.2.2 Implantable Cardioverter Defibrillators (ICD) Market, Spain, Volume (Units), by Segment, 2024-2036
6.2.3 Pacemakers Market, Spain, Volume (Units), by Segment, 2024-2036
6.3 Cardiac Rhythm Management Devices Market, Spain, Average Price ($), 2024-2036
6.4 Cardiac Rhythm Management Devices Market, Spain, Company Share by Revenue ($m), 2025
6.1.1 Cardiac Resynchronisation Therapy (CRT) Market, Spain, Revenue ($m), by Segment, 2024-2036
6.1.2 Implantable Cardioverter Defibrillators (ICD) Market, Spain, Revenue ($m), by Segment, 2024-2036
6.1.3 Pacemakers Market, Spain, Revenue ($m), by Segment, 2024-2036
6.2 Cardiac Rhythm Management Devices Market, Spain, Volume (Units), 2024-2036
6.2.1 Cardiac Resynchronisation Therapy (CRT) Market, Spain, Volume (Units), by Segment, 2024-2036
6.2.2 Implantable Cardioverter Defibrillators (ICD) Market, Spain, Volume (Units), by Segment, 2024-2036
6.2.3 Pacemakers Market, Spain, Volume (Units), by Segment, 2024-2036
6.3 Cardiac Rhythm Management Devices Market, Spain, Average Price ($), 2024-2036
6.4 Cardiac Rhythm Management Devices Market, Spain, Company Share by Revenue ($m), 2025
7 Cardiac Rhythm Management Devices Market, United Kingdom
7.1 Cardiac Rhythm Management Devices Market, United Kingdom, Revenue ($m), 2024-2036
7.1.1 Cardiac Resynchronisation Therapy (CRT) Market, United Kingdom, Revenue ($m), by Segment, 2024-2036
7.1.2 Implantable Cardioverter Defibrillators (ICD) Market, United Kingdom, Revenue ($m), by Segment, 2024-2036
7.1.3 Pacemakers Market, United Kingdom, Revenue ($m), by Segment, 2024-2036
7.2 Cardiac Rhythm Management Devices Market, United Kingdom, Volume (Units), 2024-2036
7.2.1 Cardiac Resynchronisation Therapy (CRT) Market, United Kingdom, Volume (Units), by Segment, 2024-2036
7.2.2 Implantable Cardioverter Defibrillators (ICD) Market, United Kingdom, Volume (Units), by Segment, 2024-2036
7.2.3 Pacemakers Market, United Kingdom, Volume (Units), by Segment, 2024-2036
7.3 Cardiac Rhythm Management Devices Market, United Kingdom, Average Price ($), 2024-2036
7.4 Cardiac Rhythm Management Devices Market, United Kingdom, Company Share by Revenue ($m), 2025
7.1.1 Cardiac Resynchronisation Therapy (CRT) Market, United Kingdom, Revenue ($m), by Segment, 2024-2036
7.1.2 Implantable Cardioverter Defibrillators (ICD) Market, United Kingdom, Revenue ($m), by Segment, 2024-2036
7.1.3 Pacemakers Market, United Kingdom, Revenue ($m), by Segment, 2024-2036
7.2 Cardiac Rhythm Management Devices Market, United Kingdom, Volume (Units), 2024-2036
7.2.1 Cardiac Resynchronisation Therapy (CRT) Market, United Kingdom, Volume (Units), by Segment, 2024-2036
7.2.2 Implantable Cardioverter Defibrillators (ICD) Market, United Kingdom, Volume (Units), by Segment, 2024-2036
7.2.3 Pacemakers Market, United Kingdom, Volume (Units), by Segment, 2024-2036
7.3 Cardiac Rhythm Management Devices Market, United Kingdom, Average Price ($), 2024-2036
7.4 Cardiac Rhythm Management Devices Market, United Kingdom, Company Share by Revenue ($m), 2025
8 Cardiac Rhythm Management Devices Market Pipeline Products
8.1 Cardiac Rhythm Management Devices Market Pipeline Products
8.2 Cardiac Rhythm Management Devices - Pipeline Products by Stage of Development
8.3 Cardiac Rhythm Management Devices - Pipeline Products by Segment
8.4 Cardiac Rhythm Management Devices - Pipeline Products by Territory
8.5 Cardiac Rhythm Management Devices - Pipeline Products by Regulatory Path
8.6 Cardiac Rhythm Management Devices - Pipeline Products by Estimated Approval Date
8.2 Cardiac Rhythm Management Devices - Pipeline Products by Stage of Development
8.3 Cardiac Rhythm Management Devices - Pipeline Products by Segment
8.4 Cardiac Rhythm Management Devices - Pipeline Products by Territory
8.5 Cardiac Rhythm Management Devices - Pipeline Products by Regulatory Path
8.6 Cardiac Rhythm Management Devices - Pipeline Products by Estimated Approval Date
9 Overview of Key Companies in EU5 Cardiac Rhythm Management Devices Market
9.1 Medtronic Plc
9.1.1 Company Overview
9.2 Abbott Laboratories
9.2.1 Company Overview
9.3 Biotronik SE & Co KG
9.3.1 Company Overview
9.4 Boston Scientific Corp
9.4.1 Company Overview
9.5 MicroPort Scientific Corp
9.5.1 Company Overview
9.1.1 Company Overview
9.2 Abbott Laboratories
9.2.1 Company Overview
9.3 Biotronik SE & Co KG
9.3.1 Company Overview
9.4 Boston Scientific Corp
9.4.1 Company Overview
9.5 MicroPort Scientific Corp
9.5.1 Company Overview
10 Recent Developments
10.1 Corporate Communications
10.1.1 Nov 21, 2025: Advances in Heart Failure Diagnosis Using AI Algorithms
10.1.2 Nov 18, 2025: Startup Consortium Secures €1.7M Government Investment
10.1.3 Nov 17, 2025: JenaValve Completes 1,000th Case with Trilogy Transcatheter Heart Valve System
10.1.4 Nov 13, 2025: Angelini Ventures Opens First Asia Office to Enhance Singapore Biotech Ecosystem
10.1.5 Oct 28, 2025: Tanenbaum Institute for Science in Sport and Saint-Étienne University Hospital Collaborate on Sport and Health Research
10.1.6 Oct 15, 2025: Anteris Secures European Approval to Launch DurAVR® THV Global Pivotal Trial
10.1.7 Sep 30, 2025: OUI Marks UCSF Silver Anniversary With Almost £3 Billion Raised By Spinouts
10.1.8 Sep 10, 2025: Biotronik Launches Solia CSP S To Simplify Conduction System Pacing Procedures
10.1.9 Aug 19, 2025: Medtronic Appoints John Groetelaars and Bill Jellison as Independent Directors
10.1.10 Jul 08, 2025: Medtronic Appoints Chad Spooner as Chief Financial Officer of MiniMed
10.1.11 May 21, 2025: Medtronic Announces Leadership Change in Cardiovascular Portfolio
10.2 Financial Announcements
10.2.1 Nov 13, 2025: Catheter Precision Reports Third Quarter and First Nine Months 2025 Results
10.2.2 Sep 02, 2025: Boston Scientific Announces 2025 Investor Day Meeting and Conference Call Discussing Third Quarter 2025 Results
10.2.3 May 07, 2025: Medtronic to Announce Financial Results for Its Fourth Quarter and Full Fiscal Year 2025
10.3 Government and Public Interest
10.3.1 Sep 30, 2025: Sequana Medical Features Alfapump System at 2025 Portal Intervention Symposium
10.3.2 Aug 29, 2025: Medtronic Executives to Speak at Upcoming Investor Conferences
10.3.3 Aug 22, 2025: LivaNova to Present at Baird and Morgan Stanley Global Healthcare Conferences in September
10.3.4 May 23, 2025: Medtronic Chairman and CEO Geoff Martha to Speak at Bernstein's Strategic Decisions Conference
10.4 Legal And Regulatory
10.4.1 Oct 17, 2025: Acarix Responds to G-BA Decision on Reimbursement in the German Market
10.5 Other Significant Developments
10.5.1 Nov 18, 2025: Startup Consortium Secures €1.7M Government Investment
10.5.2 Nov 13, 2025: Catheter Precision Reports Third Quarter and First Nine Months 2025 Results
10.5.3 Oct 28, 2025: Tanenbaum Institute for Science in Sport and Saint-Étienne University Hospital Collaborate on Sport and Health Research
10.5.4 Oct 17, 2025: Acarix Responds to G-BA Decision on Reimbursement in the German Market
10.5.5 Oct 17, 2025: New Value Based Procurement Guidelines Launched
10.5.6 Oct 14, 2025: Conformal Medical Begins First Patient Enrollment in E.U. for CONFORM Pivotal Trial
10.5.7 Oct 06, 2025: Implantica Completes MDSAP Recertification Audit
10.5.8 Sep 26, 2025: Government Invests Over €33 Million In Eight DTIF Projects
10.5.9 Sep 26, 2025: Health Minister Supports Barts Health Breakthrough
10.5.10 Sep 18, 2025: Ochsner Health Introduces AI Technology For Atrial Fibrillation Treatment
10.6 Product News
10.6.1 Dec 01, 2025: Catheter Precision Launches LockeT in Switzerland
10.6.2 Nov 21, 2025: Advances in Heart Failure Diagnosis Using AI Algorithms
10.6.3 Nov 19, 2025: Canon Medical Systems USA Introduces Alphenix 4D CT with Aquilion ONE/INSIGHT Edition, Now FDA Cleared
10.6.4 Nov 19, 2025: BeGraft Plus CE-Approved for Use as BEVAR Bridging Stent
10.6.5 Nov 18, 2025: Startup Consortium Secures €1.7M Government Investment
10.6.6 Nov 17, 2025: JenaValve Completes 1,000th Case with Trilogy Transcatheter Heart Valve System
10.6.7 Nov 17, 2025: Terumo Aortic Launches Fenestrated TREO Pivotal IDE Study in the United States
10.6.8 Nov 09, 2025: Uz Brussel Achieves 500 Procedures With Affera System for Heart Rhythm Disorders
10.6.9 Nov 05, 2025: Fluid Control Solutions For MedTech
10.6.10 Oct 30, 2025: Humacyte Publishes New Data Comparing Symvess to Autologous Vein in Extremity Arterial Trauma
10.6.11 Oct 28, 2025: Medicalgorithmics And Lund University Collaborate On AI Initiative For Cardiac Function Dataset
10.6.12 Oct 23, 2025: Emboline, Inc. Completes Enrollment in U.S. Pivotal IDE Trial of the Emboliner Embolic Protection Catheter
10.6.13 Oct 22, 2025: Norav Medical Launches TeleEVENT - Full Disclosure Event Recorder for Remote Cardiac Telemetry
10.6.14 Oct 15, 2025: Anteris Secures European Approval to Launch DurAVR® THV Global Pivotal Trial
10.6.15 Oct 14, 2025: Conformal Medical Begins First Patient Enrollment in E.U. for CONFORM Pivotal Trial
10.6.16 Oct 06, 2025: Implantica Completes MDSAP Recertification Audit
10.6.17 Sep 30, 2025: Sequana Medical Features Alfapump System at 2025 Portal Intervention Symposium
10.6.18 Sep 20, 2025: Zenicor Integrates Advanced AI for Arrhythmia Diagnostics
10.6.19 Sep 18, 2025: Argá Medtech Announces First Enrollments in COHERENT-AF Clinical Trial
10.6.20 Sep 18, 2025: Ochsner Health Introduces AI Technology For Atrial Fibrillation Treatment
10.6.21 Sep 11, 2025: Tricorder Study Proves AI Enhances Heart Disease Detection
10.6.22 Sep 09, 2025: Neurescue Device Receives CE Mark Approval for Non-Shockable Cardiac Arrest Treatment
10.7 Strategy And Business Planning
10.7.1 Dec 01, 2025: Catheter Precision Launches LockeT in Switzerland
10.7.2 Nov 20, 2025: New Propelus Prototype Centers
10.7.3 Nov 13, 2025: Angelini Ventures Opens First Asia Office to Enhance Singapore Biotech Ecosystem
10.7.4 Oct 28, 2025: Tanenbaum Institute for Science in Sport and Saint-Étienne University Hospital Collaborate on Sport and Health Research
10.7.5 Oct 28, 2025: Medicalgorithmics And Lund University Collaborate On AI Initiative For Cardiac Function Dataset
10.7.6 Oct 23, 2025: Biotronik And University Of Sydney Collaborate To Enhance Cardiac Care Through Digital Innovation
10.7.7 Sep 30, 2025: Icentia Reduces Inventory Time by 66% with Odoo
10.7.8 Sep 25, 2025: Philips Joins Optum Healthcare Network as Preferred Provider
10.7.9 Sep 18, 2025: Argá Medtech Announces First Enrollments in COHERENT-AF Clinical Trial
10.7.10 Sep 11, 2025: Tricorder Study Proves AI Enhances Heart Disease Detection
10.1.1 Nov 21, 2025: Advances in Heart Failure Diagnosis Using AI Algorithms
10.1.2 Nov 18, 2025: Startup Consortium Secures €1.7M Government Investment
10.1.3 Nov 17, 2025: JenaValve Completes 1,000th Case with Trilogy Transcatheter Heart Valve System
10.1.4 Nov 13, 2025: Angelini Ventures Opens First Asia Office to Enhance Singapore Biotech Ecosystem
10.1.5 Oct 28, 2025: Tanenbaum Institute for Science in Sport and Saint-Étienne University Hospital Collaborate on Sport and Health Research
10.1.6 Oct 15, 2025: Anteris Secures European Approval to Launch DurAVR® THV Global Pivotal Trial
10.1.7 Sep 30, 2025: OUI Marks UCSF Silver Anniversary With Almost £3 Billion Raised By Spinouts
10.1.8 Sep 10, 2025: Biotronik Launches Solia CSP S To Simplify Conduction System Pacing Procedures
10.1.9 Aug 19, 2025: Medtronic Appoints John Groetelaars and Bill Jellison as Independent Directors
10.1.10 Jul 08, 2025: Medtronic Appoints Chad Spooner as Chief Financial Officer of MiniMed
10.1.11 May 21, 2025: Medtronic Announces Leadership Change in Cardiovascular Portfolio
10.2 Financial Announcements
10.2.1 Nov 13, 2025: Catheter Precision Reports Third Quarter and First Nine Months 2025 Results
10.2.2 Sep 02, 2025: Boston Scientific Announces 2025 Investor Day Meeting and Conference Call Discussing Third Quarter 2025 Results
10.2.3 May 07, 2025: Medtronic to Announce Financial Results for Its Fourth Quarter and Full Fiscal Year 2025
10.3 Government and Public Interest
10.3.1 Sep 30, 2025: Sequana Medical Features Alfapump System at 2025 Portal Intervention Symposium
10.3.2 Aug 29, 2025: Medtronic Executives to Speak at Upcoming Investor Conferences
10.3.3 Aug 22, 2025: LivaNova to Present at Baird and Morgan Stanley Global Healthcare Conferences in September
10.3.4 May 23, 2025: Medtronic Chairman and CEO Geoff Martha to Speak at Bernstein's Strategic Decisions Conference
10.4 Legal And Regulatory
10.4.1 Oct 17, 2025: Acarix Responds to G-BA Decision on Reimbursement in the German Market
10.5 Other Significant Developments
10.5.1 Nov 18, 2025: Startup Consortium Secures €1.7M Government Investment
10.5.2 Nov 13, 2025: Catheter Precision Reports Third Quarter and First Nine Months 2025 Results
10.5.3 Oct 28, 2025: Tanenbaum Institute for Science in Sport and Saint-Étienne University Hospital Collaborate on Sport and Health Research
10.5.4 Oct 17, 2025: Acarix Responds to G-BA Decision on Reimbursement in the German Market
10.5.5 Oct 17, 2025: New Value Based Procurement Guidelines Launched
10.5.6 Oct 14, 2025: Conformal Medical Begins First Patient Enrollment in E.U. for CONFORM Pivotal Trial
10.5.7 Oct 06, 2025: Implantica Completes MDSAP Recertification Audit
10.5.8 Sep 26, 2025: Government Invests Over €33 Million In Eight DTIF Projects
10.5.9 Sep 26, 2025: Health Minister Supports Barts Health Breakthrough
10.5.10 Sep 18, 2025: Ochsner Health Introduces AI Technology For Atrial Fibrillation Treatment
10.6 Product News
10.6.1 Dec 01, 2025: Catheter Precision Launches LockeT in Switzerland
10.6.2 Nov 21, 2025: Advances in Heart Failure Diagnosis Using AI Algorithms
10.6.3 Nov 19, 2025: Canon Medical Systems USA Introduces Alphenix 4D CT with Aquilion ONE/INSIGHT Edition, Now FDA Cleared
10.6.4 Nov 19, 2025: BeGraft Plus CE-Approved for Use as BEVAR Bridging Stent
10.6.5 Nov 18, 2025: Startup Consortium Secures €1.7M Government Investment
10.6.6 Nov 17, 2025: JenaValve Completes 1,000th Case with Trilogy Transcatheter Heart Valve System
10.6.7 Nov 17, 2025: Terumo Aortic Launches Fenestrated TREO Pivotal IDE Study in the United States
10.6.8 Nov 09, 2025: Uz Brussel Achieves 500 Procedures With Affera System for Heart Rhythm Disorders
10.6.9 Nov 05, 2025: Fluid Control Solutions For MedTech
10.6.10 Oct 30, 2025: Humacyte Publishes New Data Comparing Symvess to Autologous Vein in Extremity Arterial Trauma
10.6.11 Oct 28, 2025: Medicalgorithmics And Lund University Collaborate On AI Initiative For Cardiac Function Dataset
10.6.12 Oct 23, 2025: Emboline, Inc. Completes Enrollment in U.S. Pivotal IDE Trial of the Emboliner Embolic Protection Catheter
10.6.13 Oct 22, 2025: Norav Medical Launches TeleEVENT - Full Disclosure Event Recorder for Remote Cardiac Telemetry
10.6.14 Oct 15, 2025: Anteris Secures European Approval to Launch DurAVR® THV Global Pivotal Trial
10.6.15 Oct 14, 2025: Conformal Medical Begins First Patient Enrollment in E.U. for CONFORM Pivotal Trial
10.6.16 Oct 06, 2025: Implantica Completes MDSAP Recertification Audit
10.6.17 Sep 30, 2025: Sequana Medical Features Alfapump System at 2025 Portal Intervention Symposium
10.6.18 Sep 20, 2025: Zenicor Integrates Advanced AI for Arrhythmia Diagnostics
10.6.19 Sep 18, 2025: Argá Medtech Announces First Enrollments in COHERENT-AF Clinical Trial
10.6.20 Sep 18, 2025: Ochsner Health Introduces AI Technology For Atrial Fibrillation Treatment
10.6.21 Sep 11, 2025: Tricorder Study Proves AI Enhances Heart Disease Detection
10.6.22 Sep 09, 2025: Neurescue Device Receives CE Mark Approval for Non-Shockable Cardiac Arrest Treatment
10.7 Strategy And Business Planning
10.7.1 Dec 01, 2025: Catheter Precision Launches LockeT in Switzerland
10.7.2 Nov 20, 2025: New Propelus Prototype Centers
10.7.3 Nov 13, 2025: Angelini Ventures Opens First Asia Office to Enhance Singapore Biotech Ecosystem
10.7.4 Oct 28, 2025: Tanenbaum Institute for Science in Sport and Saint-Étienne University Hospital Collaborate on Sport and Health Research
10.7.5 Oct 28, 2025: Medicalgorithmics And Lund University Collaborate On AI Initiative For Cardiac Function Dataset
10.7.6 Oct 23, 2025: Biotronik And University Of Sydney Collaborate To Enhance Cardiac Care Through Digital Innovation
10.7.7 Sep 30, 2025: Icentia Reduces Inventory Time by 66% with Odoo
10.7.8 Sep 25, 2025: Philips Joins Optum Healthcare Network as Preferred Provider
10.7.9 Sep 18, 2025: Argá Medtech Announces First Enrollments in COHERENT-AF Clinical Trial
10.7.10 Sep 11, 2025: Tricorder Study Proves AI Enhances Heart Disease Detection
11 Appendix
11.1Research Methodology
11.1.1 Coverage
11.1.2 Secondary Research
11.1.3 Primary Research
11.1.4 Market Modeling and Forecasting
11.1.5 Company Share Analysis
11.1.6 Benchmarking
11.2 the analyst Consulting
11.3 Contact the Publisher
11.4 Disclaimer
11.1.1 Coverage
11.1.2 Secondary Research
11.1.3 Primary Research
11.1.4 Market Modeling and Forecasting
11.1.5 Company Share Analysis
11.1.6 Benchmarking
11.2 the analyst Consulting
11.3 Contact the Publisher
11.4 Disclaimer
List of Tables
Table 1: Cardiac Rhythm Management Devices Market, Cross Country Comparison, EU5, Revenue ($m), USD Constant, 2024-2036
Table 2: Cardiac Rhythm Management Devices Market, EU5, Revenue ($m), USD Constant, 2024-2036
Table 3: Cardiac Rhythm Management Devices Market, EU5, Volume (Units), 2024-2036
Table 4: Cardiac Rhythm Management Devices Market, EU5, Volume (Units), 2024-2036
Table 5: Cardiac Rhythm Management Devices Market, EU5, Company Share by Revenue ($m), 2025
Table 6: Cardiac Rhythm Management Devices Market, France, Revenue ($m), USD Constant, 2024-2036
Table 7: Cardiac Resynchronisation Therapy (CRT) Market, France, Revenue ($m), USD Constant, 2024-2036
Table 8: Implantable Cardioverter Defibrillators (ICD) Market, France, Revenue ($m), USD Constant, 2024-2036
Table 9: Pacemakers Market, France, Revenue ($m), USD Constant, 2024-2036
Table 10: Cardiac Rhythm Management Devices Market, France, Volume (Units), 2024-2036
Table 11: Cardiac Resynchronisation Therapy (CRT) Market, France, Volume (Units), 2024-2036
Table 12: Implantable Cardioverter Defibrillators (ICD) Market, France, Volume (Units), 2024-2036
Table 13: Pacemakers Market, France, Volume (Units), 2024-2036
Table 14: Cardiac Rhythm Management Devices Market, France, Average Price ($), 2024-2036
Table 15: Cardiac Rhythm Management Devices Market, France, Company Share by Revenue ($m), USD Constant, 2025
Table 16: Cardiac Rhythm Management Devices Market, Germany, Revenue ($m), USD Constant, 2024-2036
Table 17: Cardiac Resynchronisation Therapy (CRT) Market, Germany, Revenue ($m), USD Constant, 2024-2036
Table 18: Implantable Cardioverter Defibrillators (ICD) Market, Germany, Revenue ($m), USD Constant, 2024-2036
Table 19: Pacemakers Market, Germany, Revenue ($m), USD Constant, 2024-2036
Table 20: Cardiac Rhythm Management Devices Market, Germany, Volume (Units), 2024-2036
Table 21: Cardiac Resynchronisation Therapy (CRT) Market, Germany, Volume (Units), 2024-2036
Table 22: Implantable Cardioverter Defibrillators (ICD) Market, Germany, Volume (Units), 2024-2036
Table 23: Pacemakers Market, Germany, Volume (Units), 2024-2036
Table 24: Cardiac Rhythm Management Devices Market, Germany, Average Price ($), 2024-2036
Table 25: Cardiac Rhythm Management Devices Market, Germany, Company Share by Revenue ($m), USD Constant, 2025
Table 26: Cardiac Rhythm Management Devices Market, Italy, Revenue ($m), USD Constant, 2024-2036
Table 27: Cardiac Resynchronisation Therapy (CRT) Market, Italy, Revenue ($m), USD Constant, 2024-2036
Table 28: Implantable Cardioverter Defibrillators (ICD) Market, Italy, Revenue ($m), USD Constant, 2024-2036
Table 29: Pacemakers Market, Italy, Revenue ($m), USD Constant, 2024-2036
Table 30: Cardiac Rhythm Management Devices Market, Italy, Volume (Units), 2024-2036
Table 31: Cardiac Resynchronisation Therapy (CRT) Market, Italy, Volume (Units), 2024-2036
Table 32: Implantable Cardioverter Defibrillators (ICD) Market, Italy, Volume (Units), 2024-2036
Table 33: Pacemakers Market, Italy, Volume (Units), 2024-2036
Table 34: Cardiac Rhythm Management Devices Market, Italy, Average Price ($), 2024-2036
Table 35: Cardiac Rhythm Management Devices Market, Italy, Company Share by Revenue ($m), USD Constant, 2025
Table 36: Cardiac Rhythm Management Devices Market, Spain, Revenue ($m), USD Constant, 2024-2036
Table 37: Cardiac Resynchronisation Therapy (CRT) Market, Spain, Revenue ($m), USD Constant, 2024-2036
Table 38: Implantable Cardioverter Defibrillators (ICD) Market, Spain, Revenue ($m), USD Constant, 2024-2036
Table 39: Pacemakers Market, Spain, Revenue ($m), USD Constant, 2024-2036
Table 40: Cardiac Rhythm Management Devices Market, Spain, Volume (Units), 2024-2036
Table 41: Cardiac Resynchronisation Therapy (CRT) Market, Spain, Volume (Units), 2024-2036
Table 42: Implantable Cardioverter Defibrillators (ICD) Market, Spain, Volume (Units), 2024-2036
Table 43: Pacemakers Market, Spain, Volume (Units), 2024-2036
Table 44: Cardiac Rhythm Management Devices Market, Spain, Average Price ($), 2024-2036
Table 45: Cardiac Rhythm Management Devices Market, Spain, Company Share by Revenue ($m), USD Constant, 2025
Table 46: Cardiac Rhythm Management Devices Market, United Kingdom, Revenue ($m), USD Constant, 2024-2036
Table 47: Cardiac Resynchronisation Therapy (CRT) Market, United Kingdom, Revenue ($m), USD Constant, 2024-2036
Table 48: Implantable Cardioverter Defibrillators (ICD) Market, United Kingdom, Revenue ($m), USD Constant, 2024-2036
Table 49: Pacemakers Market, United Kingdom, Revenue ($m), USD Constant, 2024-2036
Table 50: Cardiac Rhythm Management Devices Market, United Kingdom, Volume (Units), 2024-2036
Table 51: Cardiac Resynchronisation Therapy (CRT) Market, United Kingdom, Volume (Units), 2024-2036
Table 52: Implantable Cardioverter Defibrillators (ICD) Market, United Kingdom, Volume (Units), 2024-2036
Table 53: Pacemakers Market, United Kingdom, Volume (Units), 2024-2036
Table 54: Cardiac Rhythm Management Devices Market, United Kingdom, Average Price ($), 2024-2036
Table 55: Cardiac Rhythm Management Devices Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2025
Table 56: Cardiac Rhythm Management Devices Market Pipeline Products
Table 57: Cardiac Rhythm Management Devices - Pipeline Products by Stage of Development
Table 58: Cardiac Rhythm Management Devices Companies - Pipeline Products by Stage of Development
Table 59: Cardiac Rhythm Management Devices - Pipeline Products by Segment
Table 60: Cardiac Rhythm Management Devices - Pipeline Products by Territory
Table 61: Cardiac Rhythm Management Devices - Pipeline Products by Regulatory Path
Table 62: Cardiac Rhythm Management Devices - Pipeline Products by Estimated Approval Date
Table 63: Total Number of Primary Research Participants, Cardiovascular devices Market, by Country
Table 2: Cardiac Rhythm Management Devices Market, EU5, Revenue ($m), USD Constant, 2024-2036
Table 3: Cardiac Rhythm Management Devices Market, EU5, Volume (Units), 2024-2036
Table 4: Cardiac Rhythm Management Devices Market, EU5, Volume (Units), 2024-2036
Table 5: Cardiac Rhythm Management Devices Market, EU5, Company Share by Revenue ($m), 2025
Table 6: Cardiac Rhythm Management Devices Market, France, Revenue ($m), USD Constant, 2024-2036
Table 7: Cardiac Resynchronisation Therapy (CRT) Market, France, Revenue ($m), USD Constant, 2024-2036
Table 8: Implantable Cardioverter Defibrillators (ICD) Market, France, Revenue ($m), USD Constant, 2024-2036
Table 9: Pacemakers Market, France, Revenue ($m), USD Constant, 2024-2036
Table 10: Cardiac Rhythm Management Devices Market, France, Volume (Units), 2024-2036
Table 11: Cardiac Resynchronisation Therapy (CRT) Market, France, Volume (Units), 2024-2036
Table 12: Implantable Cardioverter Defibrillators (ICD) Market, France, Volume (Units), 2024-2036
Table 13: Pacemakers Market, France, Volume (Units), 2024-2036
Table 14: Cardiac Rhythm Management Devices Market, France, Average Price ($), 2024-2036
Table 15: Cardiac Rhythm Management Devices Market, France, Company Share by Revenue ($m), USD Constant, 2025
Table 16: Cardiac Rhythm Management Devices Market, Germany, Revenue ($m), USD Constant, 2024-2036
Table 17: Cardiac Resynchronisation Therapy (CRT) Market, Germany, Revenue ($m), USD Constant, 2024-2036
Table 18: Implantable Cardioverter Defibrillators (ICD) Market, Germany, Revenue ($m), USD Constant, 2024-2036
Table 19: Pacemakers Market, Germany, Revenue ($m), USD Constant, 2024-2036
Table 20: Cardiac Rhythm Management Devices Market, Germany, Volume (Units), 2024-2036
Table 21: Cardiac Resynchronisation Therapy (CRT) Market, Germany, Volume (Units), 2024-2036
Table 22: Implantable Cardioverter Defibrillators (ICD) Market, Germany, Volume (Units), 2024-2036
Table 23: Pacemakers Market, Germany, Volume (Units), 2024-2036
Table 24: Cardiac Rhythm Management Devices Market, Germany, Average Price ($), 2024-2036
Table 25: Cardiac Rhythm Management Devices Market, Germany, Company Share by Revenue ($m), USD Constant, 2025
Table 26: Cardiac Rhythm Management Devices Market, Italy, Revenue ($m), USD Constant, 2024-2036
Table 27: Cardiac Resynchronisation Therapy (CRT) Market, Italy, Revenue ($m), USD Constant, 2024-2036
Table 28: Implantable Cardioverter Defibrillators (ICD) Market, Italy, Revenue ($m), USD Constant, 2024-2036
Table 29: Pacemakers Market, Italy, Revenue ($m), USD Constant, 2024-2036
Table 30: Cardiac Rhythm Management Devices Market, Italy, Volume (Units), 2024-2036
Table 31: Cardiac Resynchronisation Therapy (CRT) Market, Italy, Volume (Units), 2024-2036
Table 32: Implantable Cardioverter Defibrillators (ICD) Market, Italy, Volume (Units), 2024-2036
Table 33: Pacemakers Market, Italy, Volume (Units), 2024-2036
Table 34: Cardiac Rhythm Management Devices Market, Italy, Average Price ($), 2024-2036
Table 35: Cardiac Rhythm Management Devices Market, Italy, Company Share by Revenue ($m), USD Constant, 2025
Table 36: Cardiac Rhythm Management Devices Market, Spain, Revenue ($m), USD Constant, 2024-2036
Table 37: Cardiac Resynchronisation Therapy (CRT) Market, Spain, Revenue ($m), USD Constant, 2024-2036
Table 38: Implantable Cardioverter Defibrillators (ICD) Market, Spain, Revenue ($m), USD Constant, 2024-2036
Table 39: Pacemakers Market, Spain, Revenue ($m), USD Constant, 2024-2036
Table 40: Cardiac Rhythm Management Devices Market, Spain, Volume (Units), 2024-2036
Table 41: Cardiac Resynchronisation Therapy (CRT) Market, Spain, Volume (Units), 2024-2036
Table 42: Implantable Cardioverter Defibrillators (ICD) Market, Spain, Volume (Units), 2024-2036
Table 43: Pacemakers Market, Spain, Volume (Units), 2024-2036
Table 44: Cardiac Rhythm Management Devices Market, Spain, Average Price ($), 2024-2036
Table 45: Cardiac Rhythm Management Devices Market, Spain, Company Share by Revenue ($m), USD Constant, 2025
Table 46: Cardiac Rhythm Management Devices Market, United Kingdom, Revenue ($m), USD Constant, 2024-2036
Table 47: Cardiac Resynchronisation Therapy (CRT) Market, United Kingdom, Revenue ($m), USD Constant, 2024-2036
Table 48: Implantable Cardioverter Defibrillators (ICD) Market, United Kingdom, Revenue ($m), USD Constant, 2024-2036
Table 49: Pacemakers Market, United Kingdom, Revenue ($m), USD Constant, 2024-2036
Table 50: Cardiac Rhythm Management Devices Market, United Kingdom, Volume (Units), 2024-2036
Table 51: Cardiac Resynchronisation Therapy (CRT) Market, United Kingdom, Volume (Units), 2024-2036
Table 52: Implantable Cardioverter Defibrillators (ICD) Market, United Kingdom, Volume (Units), 2024-2036
Table 53: Pacemakers Market, United Kingdom, Volume (Units), 2024-2036
Table 54: Cardiac Rhythm Management Devices Market, United Kingdom, Average Price ($), 2024-2036
Table 55: Cardiac Rhythm Management Devices Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2025
Table 56: Cardiac Rhythm Management Devices Market Pipeline Products
Table 57: Cardiac Rhythm Management Devices - Pipeline Products by Stage of Development
Table 58: Cardiac Rhythm Management Devices Companies - Pipeline Products by Stage of Development
Table 59: Cardiac Rhythm Management Devices - Pipeline Products by Segment
Table 60: Cardiac Rhythm Management Devices - Pipeline Products by Territory
Table 61: Cardiac Rhythm Management Devices - Pipeline Products by Regulatory Path
Table 62: Cardiac Rhythm Management Devices - Pipeline Products by Estimated Approval Date
Table 63: Total Number of Primary Research Participants, Cardiovascular devices Market, by Country
List of Figures
Figure 1: Cardiac Rhythm Management Devices Market, Cross Country Comparison, EU5, Revenue ($m), USD Constant, 2024-2036
Figure 2: Cardiac Rhythm Management Devices Market, EU5, Revenue ($m), USD Constant, 2024-2036
Figure 3: Cardiac Rhythm Management Devices Market, EU5, Volume (Units), 2024-2036
Figure 4: Cardiac Rhythm Management Devices Market, EU5, Volume (Units), 2024-2036
Figure 5: Cardiac Rhythm Management Devices Market, EU5, Company Share (%), 2025
Figure 6: Cardiac Rhythm Management Devices Market, France, Revenue ($m), USD Constant, 2024-2036
Figure 7: Cardiac Resynchronisation Therapy (CRT) Market, France, Revenue ($m), USD Constant, 2024-2036
Figure 8: Implantable Cardioverter Defibrillators (ICD) Market, France, Revenue ($m), USD Constant, 2024-2036
Figure 9: Pacemakers Market, France, Revenue ($m), USD Constant, 2024-2036
Figure 10: Cardiac Rhythm Management Devices Market, France, Volume (Units), 2024-2036
Figure 11: Cardiac Resynchronisation Therapy (CRT) Market, France, Volume (Units), 2024-2036
Figure 12: Implantable Cardioverter Defibrillators (ICD) Market, France, Volume (Units), 2024-2036
Figure 13: Pacemakers Market, France, Volume (Units), 2024-2036
Figure 14: Cardiac Rhythm Management Devices Market, France, Company Share (%), 2025
Figure 15: Cardiac Rhythm Management Devices Market, Germany, Revenue ($m), USD Constant, 2024-2036
Figure 16: Cardiac Resynchronisation Therapy (CRT) Market, Germany, Revenue ($m), USD Constant, 2024-2036
Figure 17: Implantable Cardioverter Defibrillators (ICD) Market, Germany, Revenue ($m), USD Constant, 2024-2036
Figure 18: Pacemakers Market, Germany, Revenue ($m), USD Constant, 2024-2036
Figure 19: Cardiac Rhythm Management Devices Market, Germany, Volume (Units), 2024-2036
Figure 20: Cardiac Resynchronisation Therapy (CRT) Market, Germany, Volume (Units), 2024-2036
Figure 21: Implantable Cardioverter Defibrillators (ICD) Market, Germany, Volume (Units), 2024-2036
Figure 22: Pacemakers Market, Germany, Volume (Units), 2024-2036
Figure 23: Cardiac Rhythm Management Devices Market, Germany, Company Share (%), 2025
Figure 24: Cardiac Rhythm Management Devices Market, Italy, Revenue ($m), USD Constant, 2024-2036
Figure 25: Cardiac Resynchronisation Therapy (CRT) Market, Italy, Revenue ($m), USD Constant, 2024-2036
Figure 26: Implantable Cardioverter Defibrillators (ICD) Market, Italy, Revenue ($m), USD Constant, 2024-2036
Figure 27: Pacemakers Market, Italy, Revenue ($m), USD Constant, 2024-2036
Figure 28: Cardiac Rhythm Management Devices Market, Italy, Volume (Units), 2024-2036
Figure 29: Cardiac Resynchronisation Therapy (CRT) Market, Italy, Volume (Units), 2024-2036
Figure 30: Implantable Cardioverter Defibrillators (ICD) Market, Italy, Volume (Units), 2024-2036
Figure 31: Pacemakers Market, Italy, Volume (Units), 2024-2036
Figure 32: Cardiac Rhythm Management Devices Market, Italy, Company Share (%), 2025
Figure 33: Cardiac Rhythm Management Devices Market, Spain, Revenue ($m), USD Constant, 2024-2036
Figure 34: Cardiac Resynchronisation Therapy (CRT) Market, Spain, Revenue ($m), USD Constant, 2024-2036
Figure 35: Implantable Cardioverter Defibrillators (ICD) Market, Spain, Revenue ($m), USD Constant, 2024-2036
Figure 36: Pacemakers Market, Spain, Revenue ($m), USD Constant, 2024-2036
Figure 37: Cardiac Rhythm Management Devices Market, Spain, Volume (Units), 2024-2036
Figure 38: Cardiac Resynchronisation Therapy (CRT) Market, Spain, Volume (Units), 2024-2036
Figure 39: Implantable Cardioverter Defibrillators (ICD) Market, Spain, Volume (Units), 2024-2036
Figure 40: Pacemakers Market, Spain, Volume (Units), 2024-2036
Figure 41: Cardiac Rhythm Management Devices Market, Spain, Company Share (%), 2025
Figure 42: Cardiac Rhythm Management Devices Market, United Kingdom, Revenue ($m), USD Constant, 2024-2036
Figure 43: Cardiac Resynchronisation Therapy (CRT) Market, United Kingdom, Revenue ($m), USD Constant, 2024-2036
Figure 44: Implantable Cardioverter Defibrillators (ICD) Market, United Kingdom, Revenue ($m), USD Constant, 2024-2036
Figure 45: Pacemakers Market, United Kingdom, Revenue ($m), USD Constant, 2024-2036
Figure 46: Cardiac Rhythm Management Devices Market, United Kingdom, Volume (Units), 2024-2036
Figure 47: Cardiac Resynchronisation Therapy (CRT) Market, United Kingdom, Volume (Units), 2024-2036
Figure 48: Implantable Cardioverter Defibrillators (ICD) Market, United Kingdom, Volume (Units), 2024-2036
Figure 49: Pacemakers Market, United Kingdom, Volume (Units), 2024-2036
Figure 50: Cardiac Rhythm Management Devices Market, United Kingdom, Company Share (%), 2025
Figure 51: Cardiac Rhythm Management Devices - Pipeline Products by Stage of Development
Figure 52: Cardiac Rhythm Management Devices - Pipeline Products by Segment
Figure 53: Cardiac Rhythm Management Devices - Pipeline Products by Territory
Figure 54: Cardiac Rhythm Management Devices - Pipeline Products by Regulatory Path
Figure 55: Cardiac Rhythm Management Devices - Pipeline Products by Estimated Approval Date
Figure 2: Cardiac Rhythm Management Devices Market, EU5, Revenue ($m), USD Constant, 2024-2036
Figure 3: Cardiac Rhythm Management Devices Market, EU5, Volume (Units), 2024-2036
Figure 4: Cardiac Rhythm Management Devices Market, EU5, Volume (Units), 2024-2036
Figure 5: Cardiac Rhythm Management Devices Market, EU5, Company Share (%), 2025
Figure 6: Cardiac Rhythm Management Devices Market, France, Revenue ($m), USD Constant, 2024-2036
Figure 7: Cardiac Resynchronisation Therapy (CRT) Market, France, Revenue ($m), USD Constant, 2024-2036
Figure 8: Implantable Cardioverter Defibrillators (ICD) Market, France, Revenue ($m), USD Constant, 2024-2036
Figure 9: Pacemakers Market, France, Revenue ($m), USD Constant, 2024-2036
Figure 10: Cardiac Rhythm Management Devices Market, France, Volume (Units), 2024-2036
Figure 11: Cardiac Resynchronisation Therapy (CRT) Market, France, Volume (Units), 2024-2036
Figure 12: Implantable Cardioverter Defibrillators (ICD) Market, France, Volume (Units), 2024-2036
Figure 13: Pacemakers Market, France, Volume (Units), 2024-2036
Figure 14: Cardiac Rhythm Management Devices Market, France, Company Share (%), 2025
Figure 15: Cardiac Rhythm Management Devices Market, Germany, Revenue ($m), USD Constant, 2024-2036
Figure 16: Cardiac Resynchronisation Therapy (CRT) Market, Germany, Revenue ($m), USD Constant, 2024-2036
Figure 17: Implantable Cardioverter Defibrillators (ICD) Market, Germany, Revenue ($m), USD Constant, 2024-2036
Figure 18: Pacemakers Market, Germany, Revenue ($m), USD Constant, 2024-2036
Figure 19: Cardiac Rhythm Management Devices Market, Germany, Volume (Units), 2024-2036
Figure 20: Cardiac Resynchronisation Therapy (CRT) Market, Germany, Volume (Units), 2024-2036
Figure 21: Implantable Cardioverter Defibrillators (ICD) Market, Germany, Volume (Units), 2024-2036
Figure 22: Pacemakers Market, Germany, Volume (Units), 2024-2036
Figure 23: Cardiac Rhythm Management Devices Market, Germany, Company Share (%), 2025
Figure 24: Cardiac Rhythm Management Devices Market, Italy, Revenue ($m), USD Constant, 2024-2036
Figure 25: Cardiac Resynchronisation Therapy (CRT) Market, Italy, Revenue ($m), USD Constant, 2024-2036
Figure 26: Implantable Cardioverter Defibrillators (ICD) Market, Italy, Revenue ($m), USD Constant, 2024-2036
Figure 27: Pacemakers Market, Italy, Revenue ($m), USD Constant, 2024-2036
Figure 28: Cardiac Rhythm Management Devices Market, Italy, Volume (Units), 2024-2036
Figure 29: Cardiac Resynchronisation Therapy (CRT) Market, Italy, Volume (Units), 2024-2036
Figure 30: Implantable Cardioverter Defibrillators (ICD) Market, Italy, Volume (Units), 2024-2036
Figure 31: Pacemakers Market, Italy, Volume (Units), 2024-2036
Figure 32: Cardiac Rhythm Management Devices Market, Italy, Company Share (%), 2025
Figure 33: Cardiac Rhythm Management Devices Market, Spain, Revenue ($m), USD Constant, 2024-2036
Figure 34: Cardiac Resynchronisation Therapy (CRT) Market, Spain, Revenue ($m), USD Constant, 2024-2036
Figure 35: Implantable Cardioverter Defibrillators (ICD) Market, Spain, Revenue ($m), USD Constant, 2024-2036
Figure 36: Pacemakers Market, Spain, Revenue ($m), USD Constant, 2024-2036
Figure 37: Cardiac Rhythm Management Devices Market, Spain, Volume (Units), 2024-2036
Figure 38: Cardiac Resynchronisation Therapy (CRT) Market, Spain, Volume (Units), 2024-2036
Figure 39: Implantable Cardioverter Defibrillators (ICD) Market, Spain, Volume (Units), 2024-2036
Figure 40: Pacemakers Market, Spain, Volume (Units), 2024-2036
Figure 41: Cardiac Rhythm Management Devices Market, Spain, Company Share (%), 2025
Figure 42: Cardiac Rhythm Management Devices Market, United Kingdom, Revenue ($m), USD Constant, 2024-2036
Figure 43: Cardiac Resynchronisation Therapy (CRT) Market, United Kingdom, Revenue ($m), USD Constant, 2024-2036
Figure 44: Implantable Cardioverter Defibrillators (ICD) Market, United Kingdom, Revenue ($m), USD Constant, 2024-2036
Figure 45: Pacemakers Market, United Kingdom, Revenue ($m), USD Constant, 2024-2036
Figure 46: Cardiac Rhythm Management Devices Market, United Kingdom, Volume (Units), 2024-2036
Figure 47: Cardiac Resynchronisation Therapy (CRT) Market, United Kingdom, Volume (Units), 2024-2036
Figure 48: Implantable Cardioverter Defibrillators (ICD) Market, United Kingdom, Volume (Units), 2024-2036
Figure 49: Pacemakers Market, United Kingdom, Volume (Units), 2024-2036
Figure 50: Cardiac Rhythm Management Devices Market, United Kingdom, Company Share (%), 2025
Figure 51: Cardiac Rhythm Management Devices - Pipeline Products by Stage of Development
Figure 52: Cardiac Rhythm Management Devices - Pipeline Products by Segment
Figure 53: Cardiac Rhythm Management Devices - Pipeline Products by Territory
Figure 54: Cardiac Rhythm Management Devices - Pipeline Products by Regulatory Path
Figure 55: Cardiac Rhythm Management Devices - Pipeline Products by Estimated Approval Date
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Medtronic Plc
- Abbott Laboratories
- Biotronik SE & Co KG
- Boston Scientific Corp
- MicroPort Scientific Corp

